Currently Viewing
Trump's Budget and Cancer
March 24, 2017 – Kathy LaTour
Who Am I Now, Without Cancer?
March 23, 2017 – Kathy LaTour
Did the Extra Chemo Cycles Go Too Far?
March 22, 2017 – Edward McClain
Watch for The Long-Term Side Effects of Radiation Therapy
March 22, 2017 – Ryan Hamner
Dry Brushing for Lymphedema: Does it really work?
March 22, 2017 – Bonnie Annis
In the Company of Others: Fellow Survivors
March 21, 2017 – Dana Stewart
Cancerís Side Effects: The Inside Story
March 21, 2017 – Khevin Barnes
Saying Goodbye to a Bereavement Group Is Not Easy
March 21, 2017 – Diana M. Martin
Hoping for Health Care Before, During and After Cancer
March 20, 2017 – Felicia Mitchell

Trump's Budget and Cancer

It has always been clear to me that there is a cure for cancer. It is called money.
PUBLISHED March 24, 2017
Kathy LaTour is a breast cancer survivor, author of The Breast Cancer Companion and co-founder of CURE magazine. While cancer did not take her life, she has given it willingly to educate, empower and enlighten the newly diagnosed and those who care for them.
It has always been clear to me that there is a cure for cancer. It is called money.

The research and time involved in bringing a new approach or drug to market can be more than a decade, and the money it takes for all the steps is what we see on our bill from the pharmacists. Yes, I think some of the pharmaceutical companies are charging absurd prices, but it’s the mutants who run the drug companies who are the baddies, not the researchers who spend their days in dark labs staring into microscopes as they try to find the magic bullet to kill cancer.

But if Trump has his way and passes his proposed 2017 budget, I think some of the biggest losers will be us, cancer survivors – oh and the thousands diagnosed while the plan is being argued and the millions to be diagnosed in the decades to come.

The budget, if it passes, will cut nearly $6 billion from the National Institutes of Health, a funding agency for the hundreds of hospitals and research facilities trying to find new treatments to impact cancer. This is in direct opposition to prior years when the allocations increased with voices asking for even more to fulfill vice president Joe Biden’s cancer Moonshot initiative and other biomedical efforts.

Paul McGee, managing director of field communications for the American Cancer Society, said in a tweet, “From cancer moonshot to crater in the stroke of a pen.” The 21st Century Cures Act, passed last year, authorized $1.8 billion for the Moonshot effort over seven years. The first $300 million had already been allocated.

I have been researching what the cancer pros say about the plan: Here are a few of their comments:

The Fred Hutchinson Cancer Research Center in Seattle receives significant funds from the government for cancer research. With three Nobel Prize winners, Hutch also has the Cancer Prevention program, which has made key contributions in understanding how diet, exercise and other factors influence acquiring cancer. They have produced Nobel prize-winning work on bone marrow transplantation and innovative treatments for leukemia and other blood cancers. They are working on immunotherapy in combination with conventional drugs to produce fewer side effects and are the first researchers to use a melanoma patient’s cloned T cells as the sole treatment to put cancer into long term remission.

Immunotherapy researcher Stan Riddell says the cut in funds in the new budget stops the development of new therapies and curtails the training of the next generation of scientists.

Dana-Farber Cancer Institute chief scientific officer Dr. Barrett Rollins calls the cuts a slow-motion disaster.

The president of American Society of Hematology, Dr. Kenneth Anderson, says, “The NIH  is the largest funder of biomedical research, robust federal investment in and by the agency has let to innovative bench-to-bedside discoveries that have resulted in paradigm-shifting advances in blood disease treatment and cures—from interventions that prevent stroke in young children with sickle cell disease to methods of engineering our own immune cells to attack tumors and beat cancers. . .“

He points out that billions of dollars in biomedical research and funding are under threat – with basic science to be the first on the chopping block.
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles


Sign In

Not a member? Sign up now!

Sign Up

Are you a member? Please Log In